| 000 | 00849 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517100219.0 | ||
| 264 | 0 | _c20171225 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1759-4782 | ||
| 024 | 7 |
_a10.1038/nrclinonc.2016.93 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSidaway, Peter | |
| 245 | 0 | 0 |
_aImmunotherapy: Response to nivolumab in RCC: RECISTing progression. _h[electronic resource] |
| 260 |
_bNature reviews. Clinical oncology _c07 2016 |
||
| 300 |
_a396-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aNivolumab |
| 773 | 0 |
_tNature reviews. Clinical oncology _gvol. 13 _gno. 7 _gp. 396-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrclinonc.2016.93 _zAvailable from publisher's website |
| 999 |
_c26076727 _d26076727 |
||